Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novo Nordisk A/S ADR (NY: NVO ) 127.83 +0.95 (+0.75%) Streaming Delayed Price Updated: 12:50 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 5,257,996 Open 128.05 Bid (Size) 127.82 (1) Ask (Size) 127.84 (1) Prev. Close 126.88 Today's Range 127.49 - 130.46 52wk Range 75.56 - 138.28 Shares Outstanding N/A Dividend Yield 1.38% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat Today 7:44 EDT Overall revenue fell short in Q1. Lilly stock is set to cross a key level. Via Investor's Business Daily Analyzing NYSE:NVO's Dividend Potential. Today 6:50 EDT Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) provides a good dividend, while having solid fundamentals. Via Chartmill Performance YTD +25.19% +25.19% 1 Month +0.22% +0.22% 3 Month +17.25% +17.25% 6 Month +32.60% +32.60% 1 Year +52.70% +52.70% More News Read More Decoding Novo Nordisk's Options Activity: What's the Big Picture? April 29, 2024 Via Benzinga Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks April 29, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Is Viking Therapeutics Incredibly Undervalued? April 28, 2024 Via The Motley Fool Forget Nvidia, These Unstoppable Stocks Are Better Buys April 27, 2024 Via The Motley Fool Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years April 26, 2024 Via Benzinga Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing? April 25, 2024 Via Chartmill Why Novo Nordisk Topped the Market Today April 22, 2024 Via The Motley Fool 1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On April 27, 2024 Via The Motley Fool MarketBeat Week in Review – 4/22 - 4/26 April 27, 2024 Via MarketBeat Topics Economy Exposures Economy Interest Rates What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk April 24, 2024 Via Benzinga 3 Biotech Stocks With Skyrocketing Potential: April 2024 April 24, 2024 Via InvestorPlace Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market April 24, 2024 Via The Motley Fool 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 Via InvestorPlace Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. April 24, 2024 Via The Motley Fool Better Buy: Pfizer vs. Viking Therapeutics April 23, 2024 Via The Motley Fool 3 Stocks With the Potential to Surpass Analyst Expectations for 2024 April 23, 2024 Via InvestorPlace Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending April 22, 2024 Via Benzinga Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? April 22, 2024 Via MarketBeat 2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever April 20, 2024 Via The Motley Fool MarketBeat Week in Review – 4/15 - 4/19 April 20, 2024 Via MarketBeat Topics Economy Exposures Interest Rates 3 Relatively Safe Growth Stocks You Can Buy and Hold April 20, 2024 Via The Motley Fool 3 Biotech Stocks Set to Double by 2028 April 20, 2024 Via InvestorPlace Got $500? 3 Healthcare Stocks to Buy and Hold Forever April 19, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
